Target intelligence / Profile preview

Malodorous compound

Molecular classification
Other
01

Overview

Malodorous compounds represent a broad category of volatile molecules that elicit an unpleasant olfactory response, primarily serving as metabolic byproducts of microbial activity. In human health, these compounds—most notably volatile sulfur compounds (VSCs) like hydrogen sulfide and methyl mercaptan, as well as amines like trimethylamine—are the underlying causes of conditions such as halitosis (bad breath) and bromhidrosis (body odor). They are typically produced by anaerobic bacteria residing in the oral cavity or on the skin through the degradation of proteinaceous substrates, such as sulfur-containing amino acids. While these compounds are not biological targets in the traditional pharmacological sense (i.e., they are not proteins, receptors, or enzymes), they are the focal points of various therapeutic and hygienic interventions. Such treatments aim to neutralize these molecules chemically or inhibit their formation by targeting the causative microflora. For example, metal salts like zinc are used to sequester VSCs into non-volatile precipitates, while antimicrobial agents like chlorhexidine reduce the bacterial populations responsible for their synthesis. Research has also identified specific host receptors, such as Trace-amine-associated receptor 5 (TAAR5), which detect these compounds and mediate the perception of malodor.

Other names
Volatile sulfur compoundVSCMalodorantOdorantVolatile organic compoundVOCOral malodorous compoundBody odorant
02

Mechanism of action

Chemical neutralization through the formation of non-volatile salts (e.g., zinc-sulfur complexes) or the reduction of bacterial populations that produce these compounds through antimicrobial action.

03

Biological functions

Sensory perceptionMetabolic byproductBacterial metabolite
04

Disease associations

HalitosisBody odorTrimethylaminuriaBacterial vaginosisPeriodontitis
05

Safety considerations

Alteration of oral or skin microbiomeTemporary dysgeusia (taste disturbance)Extrinsic tooth staining (associated with chlorhexidine)Potential zinc toxicity with chronic excessive nasal or oral exposure
06

Interacting drugs

Zinc gluconate

6 more in the full profile.

07

Biomarkers

Volatile sulfur compound levelsHydrogen sulfide concentrationMethyl mercaptan concentrationDimethyl sulfide concentrationTrimethylamine levelsOrganoleptic score

Beyond the preview

Go deeper on Malodorous compound.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Malodorous compound.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call